Singapore finalises guide on fast-track registration of Class B devices ahead of 1 Sept launch
This article was originally published in Clinica
Singapore's Health Sciences Authority has issued final guidance and a related explanatory document on two fast-track registration schemes for Class B devices (low-moderate risk) that will be launched on 1 September.
You may also be interested in...
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
The UK Medicines and Healthcare products Regulatory Agency wants clinical trial sponsors to integrate available regulatory flexibilities into normal practice so that their studies can withstand further potential disruptions from the COVID-19 pandemic.